Evidence map›Paper›PMID 30054353›Full record

Observational studyBMJ (Clinical research ed.)2018

Trends in outpatient antibiotic use and prescribing practice among US older adults, 2011-15: observational study.

Scott W Olesen, Michael L Barnett, Derek R MacFadden, Marc Lipsitch, Yonatan H Grad

Abstract readObservational Study
In one paragraph

Observational study in BMJ (Clinical research ed.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Drivers of Geographic Patterns in Outpatient Antibiotic Prescribing in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Scott W OlesenDepartment of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, MA, USA.
Michael L BarnettDepartment of Health Policy and Management, Harvard T H Chan School of Public Health, Boston, MA, USA.
Derek R MacFaddenDivision of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Marc LipsitchDepartment of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, MA, USA.
Yonatan H GradDepartment of Immunology and Infectious Diseases, Harvard T H Chan School of Public Health, Boston, MA, USA ygrad@hsph.harvard.edu.ORCID 0000-0001-5646-1314

Funding

Understanding and controlling antibiotic resistanceU54GM088558 · NIGMS · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM · 2009 to 2018
$26.4M
NIGMS NIH HHS U54 GM088558
6 · The paper itself

Abstract

objectiveTo identify temporal trends in outpatient antibiotic use and antibiotic prescribing practice among older adults in a high income country.

designObservational study using United States Medicare administrative claims in 2011-15.

settingMedicare, a US national healthcare program for which 98% of older adults are eligible.

participants4.5 million fee-for-service Medicare beneficiaries aged 65 years old and older. MAIN OUTCOME MEASUREMENTS: Overall rates of antibiotic prescription claims, rates of potentially appropriate and inappropriate prescribing, rates for each of the most frequently prescribed antibiotics, and rates of antibiotic claims associated with specific diagnoses. Trends in antibiotic use were estimated by multivariable regression adjusting for beneficiaries' demographic and clinical covariates.

resultsThe number of antibiotic claims fell from 1364.7 to 1309.3 claims per 1000 beneficiaries per year in 2011-14 (adjusted reduction of 2.1% (95% confidence interval 2.0% to 2.2%)), but then rose to 1364.3 claims per 1000 beneficiaries per year in 2015 (adjusted reduction of 0.20% over 2011-15 (0.09% to 0.30%)). Potentially inappropriate antibiotic claims fell from 552.7 to 522.1 per 1000 beneficiaries over 2011-14, an adjusted reduction of 3.9% (3.7% to 4.1%). Individual antibiotics had heterogeneous changes in use. For example, azithromycin claims per beneficiary decreased by 18.5% (18.2% to 18.8%) while levofloxacin claims increased by 27.7% (27.2% to 28.3%). Azithromycin use associated with each of the potentially appropriate and inappropriate respiratory diagnoses decreased, while levofloxacin use associated with each of those diagnoses increased.

conclusionAmong US Medicare beneficiaries, overall antibiotic use and potentially inappropriate use in 2011-15 remained steady or fell modestly, but individual drugs had divergent changes in use. Trends in drug use across indications were stronger than trends in use for individual indications, suggesting that guidelines and concerns about antibiotic resistance were not major drivers of change in antibiotic use.

Indexed as

Anti-Bacterial AgentsAgedAged, 80 and overDrug UtilizationFemaleHealth Services ResearchHumansInappropriate PrescribingMaleMedicareOutpatientsPractice Patterns, Physicians'United StatesAnti-Bacterial Agents

Identifiers

PMID30054353
PMCPMC6062849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.